Avenue Therapeutics, Inc.
USD0.35
+0.05 (+17.78%)
CEO
Alexandra MacLean
IPO Date
2017-06-27
Sector
Healthcare
Industry
Biotechnology
Exchange
OTC
Country
US
Open
$0.30
Prev. Close
$0.30
Day Low
$0.30
Day High
$0.35
52W Low
$0.15
52W High
$0.97
Market Cap
$0.00B
Volume
0.00M
| 33,724 |
| $0.00 |
| 3 Jan 2025 | Fortress Biotech, Inc. | 10 percent owner | Disposed | 0 | $0.00 |
| 3 Dec 2024 | Herskowitz Neil | director | S-Sale | Disposed | 23 | $2.00 |
| 7 Nov 2024 | KRANZLER JAY D | director | S-Sale | Disposed | 61 | $2.24 |
| 1 Oct 2024 | KRANZLER JAY D | director | P-Purchase | Acquired | 497 | $2.50 |
| 1 Oct 2024 | KRANZLER JAY D | director | P-Purchase | Acquired | 3 | $2.40 |
| 25 Sept 2024 | Oltmans Curtis Gale | director | A-Award | Acquired | 30,000 | $2.46 |
| 25 Sept 2024 | KRANZLER JAY D | director | A-Award | Acquired | 30,000 | $2.46 |
| 25 Sept 2024 | ROSENWALD LINDSAY A MD | director | A-Award | Acquired | 30,000 | $2.46 |